Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology ASSISTANT PROFESSOR Urology
Fingerprint
Dive into the research topics where Deepu Madduri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Cohen, A. D., Hari, P., Htut, M., Berdeja, J. G., Usmani, S. Z., Madduri, D., Olyslager, Y., Goldberg, J. D., Schecter, J. M., Jackson, C. C., Gries, K. S., Fastenau, J. M., Valluri, S., Deraedt, W., Akram, M., Crawford, R., Morrison, R., Doward, L., Morgan, K., Seldam, S. T., & 2 others, Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 68-77 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma: Clinically advanced CAR-T therapies for RRMM
Martin, T., Jackson, C. C., Pacaud, L., Madduri, D. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 22-27 6 p.Research output: Contribution to journal › Short survey › peer-review
-
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial
Criner, G. J., Lang, F. M., Gottlieb, R. L., Mathews, K. S., Wang, T. S., Rice, T. W., Madduri, D., Bellam, S., Jeanfreau, R., Case, A. H., Glassberg, M. K., Lyon, G. M., Ahmad, K., Mendelson, R., DiMaio, J. M., Tran, M. A. P., Spak, C. W., Abbasi, J. A., Davis, S. G., Ghamande, S., & 3 others, 1 Jun 2022, In: American Journal of Respiratory and Critical Care Medicine. 205, 11, p. 1290-1299 10 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
A Three-Gene Signature Predicts Response to Selinexor in Multiple Myeloma
Restrepo, P., Bhalla, S., Ghodke-Puranik, Y., Aleman, A., Leshchenko, V., Melnekoff, D. T., Agte, S., Jiang, J., Madduri, D., Richter, J., Richard, S., Chari, A., Cho, H. J., Jagannath, S., Walker, C. J., Landesman, Y., Laganà, A. & Parekh, S., 1 Jun 2022, In: JCO Precision Oncology. 6, e2200147.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up
Martin, T., Usmani, S. Z., Berdeja, J. G., Agha, M., Cohen, A. D., Hari, P., Avigan, D., Deol, A., Htut, M., Lesokhin, A., Munshi, N. C., O'donnell, E., Stewart, A. K., Schecter, J. M., Goldberg, J. D., Jackson, C. C., Yeh, T. M., Banerjee, A., Allred, A., Zudaire, E., & 8 others, 1 May 2022, In: Journal of Clinical Oncology. 19, JCO.22.00842.Research output: Contribution to journal › Article › peer-review
Open Access21 Scopus citations
Press / Media
-
Could These 3 Researchers Transform the Fates of Patients With Multiple Myeloma?
22/09/22
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Potentially Serious Side Effect Seen in Patient after Immunotherapy
Oliver van Oekelen, Samir Parekh, Adolfo Aleman, Seunghee Kim-Schulze, Charles Stacy, Somali Gavane, Julie Teruya-Feldstein, Deepu Madduri, Joshua Brody, Adeeb Rahman & Sundar Jagannath
10/12/21 → 11/12/21
9 items of Media coverage
Press/Media
-
Scientists identify new types of a blood cancer and potential targeted treatments
Adolfo Aleman, David Melnekoff, Joshua Richter, Joel Dudley, Samir Parekh, Violetta V. Leshchenko, Kenen Onel, Deepu Madduri, Ajai Chari, Hearn Cho & Sundar Jagannath
17/11/21
1 item of Media coverage
Press/Media
-
Cilta-Cel Induces Deep and Durable Responses in Patients with Multiple Myeloma
29/07/21
1 item of Media coverage
Press/Media
-
Many Factors Influence Which Cell-Based Treatment Options are Best for Patients with Multiple Myeloma, Expert SaysArticle
30/03/21
1 item of Media coverage
Press/Media